SCHEMBL975487

SCHEMBL975487

O=C(NO)c1sc(N2CCCCC2)nc1-c1ccccc1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 10/20 0.71
HTT P42858 5/20 0.71
NPSR1 Q6W5P4 3/20 0.71
ALOX5 P09917 3/20 0.71
SMN1; SMN2 Q16637 3/20 0.71
TDP1 Q9NUW8 2/20 0.71
MEN1 O00255 1/20 0.63
MAPT P10636 1/20 0.63
KMT2A Q03164 1/20 0.63
LMNA P02545 2/20 0.61
GAA P10253 3/20 0.61
HPGD P15428 1/20 0.61
CDC7 O00311 1/20 0.53
DBF4 Q9UBU7 1/20 0.53
L3MBTL1 Q9Y468 1/20 0.52
PTGS2 P35354 1/20 0.50
KDM4E B2RXH2 1/20 0.47
GLA P06280 1/20 0.47
AR P10275 1/20 0.47
TP53 P04637 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8823061 0.87 ALDH1A1 (0.78) ALDH1A1HTTNPSR1ALOX5SMN1; SMN2
SCHEMBL976260 0.78 CDC7 (0.46) ALDH1A1HTTNPSR1ALOX5SMN1; SMN2
SCHEMBL19909712 0.75 ALDH1A1 (0.65) ALDH1A1HTTNPSR1ALOX5SMN1; SMN2
SCHEMBL975727 0.75 CDC7 (0.86) ALDH1A1NPSR1SMN1; SMN2MEN1MAPT
SCHEMBL8823050 0.74 ALDH1A1 (0.79) ALDH1A1HTTNPSR1ALOX5SMN1; SMN2
SCHEMBL19051366 0.74 AR (0.74) ALDH1A1HTTNPSR1ALOX5SMN1; SMN2
SCHEMBL19909686 0.73 ALDH1A1 (0.63) ALDH1A1HTTNPSR1ALOX5SMN1; SMN2
SCHEMBL974949 0.73 CDC7 (0.46) ALDH1A1HTTNPSR1ALOX5SMN1; SMN2
SCHEMBL20764290 0.72 ALDH1A1 (0.57) ALDH1A1HTTNPSR1ALOX5SMN1; SMN2
SCHEMBL976446 0.72 CDC7 (0.62) ALDH1A1HTTNPSR1ALOX5LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8673911-B2 Inhibitors of histone deacetylase METHYLGENE INC. (CA) 2014-03-18 US disclosed
US-8673911-B2 Inhibitors of histone deacetylase METHYLGENE INC. (CA) 2014-03-18 US disclosed
US-8673911-B2 Inhibitors of histone deacetylase METHYLGENE INC. (CA) 2014-03-18 US disclosed
US-20140045850-A1 INHIBITORS OF HISTONE DEACETYLASE METHYLGENE INC. (CA) 2014-02-13 US disclosed
US-20140045850-A1 INHIBITORS OF HISTONE DEACETYLASE METHYLGENE INC. (CA) 2014-02-13 US disclosed
US-20140045850-A1 INHIBITORS OF HISTONE DEACETYLASE METHYLGENE INC. (CA) 2014-02-13 US disclosed
US-20110021771-A1 INHIBITORS OF HISTONE DEACETYLASE METHYLGENE INC. (CA) 2011-01-27 US disclosed
US-20110021771-A1 INHIBITORS OF HISTONE DEACETYLASE METHYLGENE INC. (CA) 2011-01-27 US disclosed
US-20110021771-A1 INHIBITORS OF HISTONE DEACETYLASE METHYLGENE INC. (CA) 2011-01-27 US disclosed
EP-2217588-A1 INHIBITORS OF HISTONE DEACETYLASE Methylgene, Inc. (CA) 2010-08-18 EP disclosed
WO-2009055917-A1 INHIBITORS OF HISTONE DEACETYLASE METHYLGENE INC. (CA) 2009-05-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110021771-A1 INHIBITORS OF HISTONE DEACETYLASE HDAC1, HDAC11, HDAC3 ALDH1A1 699/4885HTT 878/4885NPSR1 453/4885
US-20140045850-A1 INHIBITORS OF HISTONE DEACETYLASE HDAC1, HDAC11, HDAC3 ALDH1A1 699/4885HTT 878/4885NPSR1 453/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.